API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.indianpharmapost.com/diagnostic-center/arvinas-and-pfizer-announce-updated-clinical-data-from-phase-1b-trial-of-vepdegestrant-in-combination-with-palbociclib-15660
https://www.globenewswire.com/news-release/2024/05/16/2883219/0/en/Arvinas-and-Pfizer-Announce-Updated-Clinical-Data-from-Phase-1b-Trial-of-Vepdegestrant-in-Combination-with-Palbociclib-IBRANCE.html
https://www.globenewswire.com/news-release/2024/05/09/2879260/0/en/Arvinas-Announces-Upcoming-Vepdegestrant-Poster-Presentations-at-the-2024-European-Society-for-Medical-Oncology-ESMO-Breast-Cancer-Annual-Congress.html
https://www.globenewswire.com//news-release/2024/02/14/2829038/0/en/Carrick-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1b-2-Clinical-Trial-of-Samuraciclib-in-Combination-with-Vepdegestrant-in-Patients-with-Advanced-Breast-Cancer.html
https://www.globenewswire.com//news-release/2024/02/06/2824113/0/en/Arvinas-and-Pfizer-s-Vepdegestrant-ARV-471-Receives-FDA-Fast-Track-Designation-for-the-Treatment-of-Patients-with-ER-HER2-Metastatic-Breast-Cancer.html
https://www.globenewswire.com//news-release/2023/11/28/2787397/0/en/Arvinas-and-Pfizer-Announce-Updated-Vepdegestrant-ARV-471-Data-to-be-Presented-at-the-2023-San-Antonio-Breast-Cancer-Symposium.html
https://www.globenewswire.com//news-release/2023/10/15/2760265/0/en/Arvinas-and-Pfizer-Announce-Upcoming-Vepdegestrant-ARV-471-Poster-Presentation-at-ESMO-Congress-2023.html